538 related articles for article (PubMed ID: 1446808)
1. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
Gerling IC; Serreze DV; Christianson SW; Leiter EH
Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
[TBL] [Abstract][Full Text] [Related]
2. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
Gerling IC; Atkinson MA; Leiter EH
J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
[TBL] [Abstract][Full Text] [Related]
3. Prevention of overt diabetes and insulitis by intrathymic injection of syngeneic islets in newborn nonobese diabetic (NOD) mice.
Nomura Y; Stein E; Mullen Y
Transplantation; 1993 Sep; 56(3):638-42. PubMed ID: 8212162
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors.
Christianson SW; Shultz LD; Leiter EH
Diabetes; 1993 Jan; 42(1):44-55. PubMed ID: 8093606
[TBL] [Abstract][Full Text] [Related]
5. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice.
Rohane PW; Shimada A; Kim DT; Edwards CT; Charlton B; Shultz LD; Fathman CG
Diabetes; 1995 May; 44(5):550-4. PubMed ID: 7729614
[TBL] [Abstract][Full Text] [Related]
6. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate beta-cell antigens.
Cetkovic-Cvrlje M; Gerling IC; Muir A; Atkinson MA; Elliott JF; Leiter EH
Diabetes; 1997 Dec; 46(12):1975-82. PubMed ID: 9392483
[TBL] [Abstract][Full Text] [Related]
7. Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.
Grewal IS; Grewal KD; Wong FS; Picarella DE; Janeway CA; Flavell RA
J Exp Med; 1996 Nov; 184(5):1963-74. PubMed ID: 8920883
[TBL] [Abstract][Full Text] [Related]
8. Transfer of diabetes from prediabetic NOD mice to NOD-SCID/SCID mice: association with pancreatic insulin content.
Füchtenbusch M; Larger E; Thebault K; Boitard C
Horm Metab Res; 2005 Feb; 37(2):63-7. PubMed ID: 15778920
[TBL] [Abstract][Full Text] [Related]
9. Prevention of diabetes and insulitis by neonatal intrathymic islet administration in NOD mice.
Charlton B; Taylor-Edwards C; Tisch R; Fathman CG
J Autoimmun; 1994 Oct; 7(5):549-60. PubMed ID: 7840850
[TBL] [Abstract][Full Text] [Related]
10. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
Lakey JR; Singh B; Warnock GL; Rajotte RV
Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
[TBL] [Abstract][Full Text] [Related]
11. Xenografts of porcine islets immunoprotected in hollow fibres reduce the incidence of diabetes in non-obese diabetic mice.
Chaillous L; Darquy S; Maugendre S; Rivereau AS; Reach G; Saï P
Diabetologia; 1996 May; 39(5):523-9. PubMed ID: 8739911
[TBL] [Abstract][Full Text] [Related]
12. Intrathymic transplantation of islet antigen affects CD8+ diabetogenic T-cells resulting in tolerance to autoimmune IDDM.
Baumann EE; Buckingham F; Herold KC
Diabetes; 1995 Aug; 44(8):871-7. PubMed ID: 7621990
[TBL] [Abstract][Full Text] [Related]
13. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
[TBL] [Abstract][Full Text] [Related]
14. Intrathymic islet transplantation in the canine: I. Histological and functional evidence of autologous intrathymic islet engraftment and survival in pancreatectomized recipients.
Levy MM; Ketchum RJ; Tomaszewski JE; Naji A; Barker CF; Brayman KL
Transplantation; 2002 Mar; 73(6):842-52. PubMed ID: 11923682
[TBL] [Abstract][Full Text] [Related]
15. Survival and function of syngeneic rat islet grafts placed within the thymus versus under the kidney capsule.
Rayat GR; Korbutt GS; Elliott JF; Rajotte RV
Cell Transplant; 1997; 6(6):597-602. PubMed ID: 9440869
[TBL] [Abstract][Full Text] [Related]
16. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.
Oluwole OO; Depaz HA; Gopinathan R; Ali A; Garrovillo M; Jin MX; Hardy MA; Oluwole SF
Diabetes; 2001 Jul; 50(7):1546-52. PubMed ID: 11423475
[TBL] [Abstract][Full Text] [Related]
17. Suppression of diabetes incidence by intrathymic islet isografting in newborn NOD mice.
Nomura Y; Stein E; Mullen Y
Transplant Proc; 1992 Dec; 24(6):2903. PubMed ID: 1465992
[No Abstract] [Full Text] [Related]
18. Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane.
Duvivier-Kali VF; Omer A; Parent RJ; O'Neil JJ; Weir GC
Diabetes; 2001 Aug; 50(8):1698-705. PubMed ID: 11473027
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
20. The B-subunit of cholera toxin induces immunoregulatory cells and prevents diabetes in the NOD mouse.
Sobel DO; Yankelevich B; Goyal D; Nelson D; Mazumder A
Diabetes; 1998 Feb; 47(2):186-91. PubMed ID: 9519711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
